ConductScience.org, home

Paper22155308

Inactivation of a class A and a class C β-lactamase by 6β-(hydroxymethyl)penicillanic acid sulfone.

Papp-Wallace KM and 16 others. Biochem Pharmacol, 2012. Cited by 14 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Inactivation of a class A and a class C β-lactamase by 6β-(hydroxymethyl)penicillanic acid sulfone. Papers, record 22155308. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22155308

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inactivation of a class A and a class C β-lactamase by 6β-(hydroxymethyl)penicillanic acid sulfone.
PubMed
Journal
Biochem Pharmacol
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.52
iCite
Revised in PubMed
2025-05-29
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Papp-Wallace KMKrisztina M
2Bethel CRChristopher R
3Gootz TDThomas D
4Shang WWenchi
5Stroh JJustin
6Lau WWilliam
7McLeod DDale
8Price LLoren
9Marfat AAnthony
10Distler AAnne
11Drawz SMSarah M
12Chen HHansong
13Harry EEmily
14Nottingham MMicheal
15Carey PRPaul R
16Buynak JDJohn D
17Bonomo RARobert A

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Bacterial ProteinsMajor topic
SulbactamMajor topic
beta-LactamasesMajor topic
Catalytic Domain
Computer Simulation
Escherichia coli
Models, Molecular
Molecular Structure
Protein Conformation
Pseudomonas aeruginosa
beta-Lactamase Inhibitors

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI063517NIAID NIH HHSUnited StatesR01AI063517PubMed and NIHNIH RePORTER
R01 GM054072NIGMS NIH HHSUnited StatesR01GM054072PubMed and NIHNIH RePORTER
T32 GM007250NIGMS NIH HHSUnited StatesT32GM007250PubMed and NIHNIH RePORTER
R01 GM54072NIGMS NIH HHSUnited StatesR01GM054072PubMed and NIHNIH RePORTER

Download CSV of grants

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120822105Design, synthesis, and crystal structures of 6-alkylidene-2'-substituted penicillanic acid sulfones as potent inhibitors of Acinetobacter baumannii OXA-24 carbapenemase.J Am Chem Soc2010https://conductscience.org/library/papers/20822105PubMed
221404358Exploring sequence requirements for C₃/C₄ carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase.Protein Sci2011https://conductscience.org/library/papers/21404358PubMed
310837472Mechanism of inhibition of the class A beta -lactamases PC1 and TEM-1 by tazobactam. Observation of reaction products by electrospray ionization mass spectrometry.J Biol Chem2000https://conductscience.org/library/papers/10837472PubMed
46332621Purification of beta-lactamases by affinity chromatography on phenylboronic acid-agarose.Biochem J1984https://conductscience.org/library/papers/6332621PubMed
5102306266-(1-Hydroxyalkyl)penam sulfone derivatives as inhibitors of class A and class C beta-lactamases I.Bioorg Med Chem Lett1999https://conductscience.org/library/papers/10230626PubMed
815279575The discovery and development of modified penicillin- and cephalosporin-derived beta-lactamase inhibitors.Curr Med Chem2004https://conductscience.org/library/papers/15279575PubMed
919995920Updated functional classification of beta-lactamases.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/19995920PubMed
1012109906Structure-based approach for binding site identification on AmpC beta-lactamase.J Med Chem2002https://conductscience.org/library/papers/12109906PubMed
118388201Kinetic interactions of tazobactam with beta-lactamases from all major structural classes.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8388201PubMed
1216041072Structure of the wild-type TEM-1 beta-lactamase at 1.55 A and the mutant enzyme Ser70Ala at 2.1 A suggest the mode of noncovalent catalysis for the mutant enzyme.Acta Crystallogr D Biol Crystallogr2005https://conductscience.org/library/papers/16041072PubMed
132613337Biochemical characteristics of extended broad spectrum beta-lactamases.Infection1989https://conductscience.org/library/papers/2613337PubMed
147018564Inactivation of the RTEM beta-lactamase from Escherichia coli. Interaction of penam sulfones with enzyme.Biochemistry1981https://conductscience.org/library/papers/7018564PubMed
157574506A functional classification scheme for beta-lactamases and its correlation with molecular structure.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7574506PubMed
1620065329Three decades of beta-lactamase inhibitors.Clin Microbiol Rev2010https://conductscience.org/library/papers/20065329PubMed
1710450969The synthesis and evaluation of 6-alkylidene-2'beta-substituted penam sulfones as beta-lactamase inhibitors.Bioorg Med Chem Lett1999https://conductscience.org/library/papers/10450969PubMed
1811327849Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam.Biochemistry2001https://conductscience.org/library/papers/11327849PubMed
194975648Chemical structure of bacterial penicillinases.Nature1969https://conductscience.org/library/papers/4975648PubMed
2014980686Penicillin-derived inhibitors that simultaneously target both metallo- and serine-beta-lactamases.Bioorg Med Chem Lett2004https://conductscience.org/library/papers/14980686PubMed
216109327The structure of beta-lactamases.Philos Trans R Soc Lond B Biol Sci1980https://conductscience.org/library/papers/6109327PubMed
2321129961Modifications of the C6-substituent of penicillin sulfones with the goal of improving inhibitor recognition and efficacy.Bioorg Med Chem Lett2011https://conductscience.org/library/papers/21129961PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
29675000Exploring Additional Dimensions of Complexity in Inhibitor Design for Serine β-Lactamases: Mechanistic and Intra- and Inter-molecular Chemistry Approaches.Front Microbiol2018https://conductscience.org/library/papers/29675000PubMed
29439391Application of Nanoparticle Technology to Reduce the Anti-Microbial Resistance through β-Lactam Antibiotic-Polymer Inclusion Nano-Complex.Pharmaceuticals (Basel)2018https://conductscience.org/library/papers/29439391PubMed
28740144Search for non-lactam inhibitors of mtb β-lactamase led to its open shape in apo state: new concept for antibiotic design.Sci Rep2017https://conductscience.org/library/papers/28740144PubMed
26813250One ring to rule them all: Current trends in combating bacterial resistance to the β-lactams.Protein Sci2016https://conductscience.org/library/papers/26813250PubMed
25536850Detecting a quasi-stable imine species on the reaction pathway of SHV-1 β-lactamase and 6β-(hydroxymethyl)penicillanic acid sulfone.Biochemistry2015https://conductscience.org/library/papers/25536850PubMed
24454944Penam sulfones and β-lactamase inhibition: SA2-13 and the importance of the C2 side chain length and composition.PLoS One2014https://conductscience.org/library/papers/24454944PubMed
24379206New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24379206PubMed
24235094A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenems.J Antimicrob Chemother2014https://conductscience.org/library/papers/24235094PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22155308

GET https://conductscience.org/api/papers/v1/22155308/authors